{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T05:12:10Z","timestamp":1739164330813,"version":"3.37.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,27]]},"DOI":"10.1097\/tp.0b013e31819f1001","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T21:08:42Z","timestamp":1242940122000},"page":"1221-1224","source":"Crossref","is-referenced-by-count":8,"title":["Rimonabant Affects Cyclosporine A, but Not Tacrolimus Pharmacokinetics in Renal Transplant Recipients"],"prefix":"10.1097","volume":"87","author":[{"given":"Rune","family":"Amundsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"\u00c5sberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida","family":"Robertsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils T.","family":"Vethe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein","family":"Bergan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Midtvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation.","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R2-18-20210129","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ndt\/14.3.648","article-title":"Cardiovascular morbidity and risk factors in renal transplant patients.","volume":"14","author":"Aakhus","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"R3-18-20210129","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease.","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R4-18-20210129","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1046\/j.1523-1755.1999.0550031104.x","article-title":"Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients.","volume":"55","author":"Hausberg","year":"1999","journal-title":"Kidney Int"},{"key":"R5-18-20210129","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age 1.","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"R6-18-20210129","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.ki.5000116","article-title":"The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events.","volume":"69","author":"Hjelmesaeth","year":"2006","journal-title":"Kidney Int"},{"key":"R7-18-20210129","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2337\/diacare.24.12.2121","article-title":"Insulin resistance after renal transplantation: Impact of immunosuppressive and antihypertensive therapy.","volume":"24","author":"Hjelmesaeth","year":"2001","journal-title":"Diabetes Care"},{"key":"R8-18-20210129","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial.","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"R9-18-20210129","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00007890-200112150-00013","article-title":"Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril1.","volume":"72","author":"Midtvedt","year":"2001","journal-title":"Transplantation"},{"key":"R10-18-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/mvre.2000.2247","article-title":"Each administration of cyclosporin A enhances skin microvascular reactivity in renal transplant recipients.","volume":"60","author":"\u00c5sberg","year":"2000","journal-title":"Microvasc Res"},{"key":"R11-18-20210129","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2796.2008.01922.x","article-title":"The epidemiology of obesity: The size of the problem.","volume":"263","author":"James","year":"2008","journal-title":"J Intern Med"},{"key":"R12-18-20210129","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.transproceed.2007.09.001","article-title":"Posttransplant overweight and obesity: Myth or reality?","volume":"39","author":"Jezior","year":"2007","journal-title":"Transplant Proc"},{"key":"R13-18-20210129","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/j.transproceed.2007.08.055","article-title":"Weight reduction in renal transplant recipients program: The first successes.","volume":"39","author":"Jezior","year":"2007","journal-title":"Transplant Proc"},{"key":"R14-18-20210129","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1053\/j.ajkd.2004.01.018","article-title":"Obesity and kidney transplantation.","volume":"43","author":"Jindal","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R15-18-20210129","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0024-3205(02)02474-8","article-title":"Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart.","volume":"72","author":"Bouchard","year":"2003","journal-title":"Life Sci"},{"key":"R16-18-20210129","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-18-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/bbrc.1996.1766","article-title":"An endogenous cannabinoid as an endothelium-derived vasorelaxant.","volume":"229","author":"Randall","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"R18-18-20210129","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study.","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"key":"R19-18-20210129","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjp.0705160","article-title":"Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.","volume":"138","author":"Ho","year":"2003","journal-title":"Br J Pharmacol"},{"key":"R20-18-20210129","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2146\/060258","article-title":"Rimonabant: A novel selective cannabinoid-1 receptor antagonist for treatment of obesity.","volume":"64","author":"Patel","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"R21-18-20210129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0163-7258(93)90059-M","article-title":"Cyclosporin metabolism in transplant patients.","volume":"57","author":"Christians","year":"1993","journal-title":"Pharmacol Ther"},{"key":"R22-18-20210129","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0090-9556(25)08793-8","article-title":"Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat.","volume":"20","author":"Sattler","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"R23-18-20210129","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","article-title":"Human P-glycoprotein transports cyclosporin A and FK506.","volume":"268","author":"Saeki","year":"1993","journal-title":"J Biol Chem"},{"key":"R24-18-20210129","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2217\/14796678.3.5.497","article-title":"Rimonabant: A novel approach for the treatment of obesity and cardiometabolic risk by blockade of the endocannabinoid system.","volume":"3","author":"Colleran","year":"2007","journal-title":"Future Cardiol"},{"key":"R25-18-20210129","first-page":"1082","article-title":"Lack of effect of rimonabant on the pharmacokinetics of midazolam.","volume":"45","author":"Grandison","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R26-18-20210129","first-page":"1081","article-title":"Lack of effect of rimonabant on the pharmacokinetics of digoxin.","volume":"45","author":"Kanamaluru","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R27-18-20210129","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","article-title":"Declaration of Helsinki: Ethical principles for medical research involving human subjects.","volume":"284","year":"2000","journal-title":"JAMA"},{"key":"R28-18-20210129","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jchromb.2007.01.039","article-title":"Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry.","volume":"852","author":"Falck","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R30-18-20210129","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/00007890-199506270-00007","article-title":"Predicting glomerular filtration rate after kidney transplantation.","volume":"59","author":"Nankivell","year":"1995","journal-title":"Transplantation"},{"year":"2006","key":"R31-18-20210129","article-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO\/IDF consultation."},{"year":"2001","key":"R32-18-20210129","article-title":"Note for guidance on the investigation of bioavailability and bioequivalence."},{"key":"R33-18-20210129","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1111\/j.1600-6143.2005.01005.x","article-title":"Combined therapy with atorvastatin and calcineurin inhibitors: No interactions with tacrolimus.","volume":"5","author":"Lemahieu","year":"2005","journal-title":"Am J Transplant"},{"key":"R34-18-20210129","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"R35-18-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: A randomized controlled trial.","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"R36-18-20210129","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"R37-18-20210129","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/sj.ki.5002540","article-title":"Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese zucker rats.","volume":"72","author":"Janiak","year":"2007","journal-title":"Kidney Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200904270-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T16:48:49Z","timestamp":1739119729000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200904270-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,27]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31819f1001","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2009,4,27]]}}}